Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 7, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $36 on, Nov 7th, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $44 to $36 on, Nov 7th, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bradley
- Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $50 on, Thursday, August 10th, 2023
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $38 on, Thursday, August 10th, 2023
